IL132993A0 - Therapeutic agent for erection failure - Google Patents
Therapeutic agent for erection failureInfo
- Publication number
- IL132993A0 IL132993A0 IL13299398A IL13299398A IL132993A0 IL 132993 A0 IL132993 A0 IL 132993A0 IL 13299398 A IL13299398 A IL 13299398A IL 13299398 A IL13299398 A IL 13299398A IL 132993 A0 IL132993 A0 IL 132993A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agent
- erection failure
- erection
- failure
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Otolaryngology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4029797P | 1997-05-29 | 1997-05-29 | |
| JP34413497 | 1997-11-29 | ||
| PCT/JP1998/002378 WO1998053819A1 (fr) | 1997-05-29 | 1998-05-29 | Agent therapeutique destine a traiter l'anerection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL132993A0 true IL132993A0 (en) | 2001-03-19 |
Family
ID=26577702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13299398A IL132993A0 (en) | 1997-05-29 | 1998-05-29 | Therapeutic agent for erection failure |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0992240A4 (no) |
| KR (1) | KR20010012995A (no) |
| CN (1) | CN1309561A (no) |
| AU (1) | AU739417B2 (no) |
| BR (1) | BR9809508A (no) |
| CA (1) | CA2291256A1 (no) |
| IL (1) | IL132993A0 (no) |
| NO (1) | NO995823L (no) |
| WO (1) | WO1998053819A1 (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA9810766B (en) * | 1997-11-28 | 1999-05-25 | Mochida Pharm Co Ltd | Novel compounds having cgmp-pde inhibitory activity |
| GT199900061A (es) * | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
| TWI223598B (en) * | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
| US6200591B1 (en) * | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
| AU1414200A (en) * | 1998-12-02 | 2000-06-19 | Mochida Pharmaceutical Co., Ltd. | Preparations for intraurethral administration |
| GB9828340D0 (en) * | 1998-12-22 | 1999-02-17 | Novartis Ag | Organic compounds |
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| WO2000054777A1 (en) * | 1999-03-16 | 2000-09-21 | Pentech Pharmaceuticals, Inc. | Controlled release of sildenafil delivered by sublingual or buccal administration |
| TWI265925B (en) | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
| CA2391968A1 (en) * | 1999-11-18 | 2001-05-25 | Natco Pharma Limited | An improved pharmaceutical composition for treating male erectile dysfunction |
| DE10010612A1 (de) * | 2000-03-03 | 2001-09-27 | Merck Patent Gmbh | Verwendung von PDE V-Inhibitoren |
| AU2001255849B8 (en) | 2000-04-19 | 2006-04-27 | Lilly Icos, Llc. | PDE-V inhibitors for treatment of Parkinson's Disease |
| AU2001273545A1 (en) * | 2000-07-19 | 2002-01-30 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
| DE10118306A1 (de) * | 2001-04-12 | 2002-10-17 | Bayer Ag | Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation |
| EP1404336A1 (en) * | 2001-06-14 | 2004-04-07 | Sampad Bhattacharya | Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis |
| WO2004011029A2 (en) | 2002-07-26 | 2004-02-05 | Adams Kenneth W | Pharmaceutical compositions for penis enlargement |
| US7662831B2 (en) | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
| CN101429166B (zh) * | 2007-11-07 | 2013-08-21 | 上海特化医药科技有限公司 | 喹唑啉酮衍生物及其制备方法和用途 |
| EP2526926A1 (de) * | 2011-05-25 | 2012-11-28 | Justus-Liebig-Universität Gießen | Biokompatible Nanopolymerpartikel mit Wirkstoffen für die pulmonale Applikation |
| ES2692663T3 (es) * | 2011-12-26 | 2018-12-04 | Tritech Biopharmaceuticals Co. Ltd. | Método y composición farmacéutica mejorada para mejorar la entrega transdérmica del inhibidor PDE-5 |
| CA2994709A1 (en) * | 2015-08-03 | 2017-02-09 | Synergistic Therapeutics, Llc | Sexual dysfunction therapeutic gel |
| JP6865933B2 (ja) | 2018-02-23 | 2021-04-28 | 株式会社Ｍｅｉｓ Ｔｅｃｈｎｏｌｏｇｙ | 勃起不全治療剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9301192D0 (en) * | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
| DE69514794T2 (de) * | 1994-04-22 | 2000-07-27 | Pentech Pharmaceuticals Inc | Sublinguale dosierungsformen enthaltend apomorphin zur verwendung bei der behandlung von erektiler dysfunktion |
| WO1997045427A1 (fr) * | 1996-05-31 | 1997-12-04 | Mochida Pharmaceutical Co., Ltd. | DERIVES DE PYRIDOCARBAZOLE AYANT UN EFFET INHIBITEUR DE cGMP-PDE |
| GB9612514D0 (en) * | 1996-06-14 | 1996-08-14 | Pfizer Ltd | Novel process |
-
1998
- 1998-05-29 CN CN98807614A patent/CN1309561A/zh active Pending
- 1998-05-29 IL IL13299398A patent/IL132993A0/xx unknown
- 1998-05-29 AU AU74548/98A patent/AU739417B2/en not_active Ceased
- 1998-05-29 BR BR9809508-0A patent/BR9809508A/pt not_active IP Right Cessation
- 1998-05-29 KR KR1019997010967A patent/KR20010012995A/ko not_active Application Discontinuation
- 1998-05-29 CA CA002291256A patent/CA2291256A1/en not_active Abandoned
- 1998-05-29 EP EP98921878A patent/EP0992240A4/en not_active Withdrawn
- 1998-05-29 WO PCT/JP1998/002378 patent/WO1998053819A1/ja not_active Application Discontinuation
-
1999
- 1999-11-26 NO NO995823A patent/NO995823L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU739417B2 (en) | 2001-10-11 |
| NO995823L (no) | 2000-01-28 |
| WO1998053819A1 (fr) | 1998-12-03 |
| CN1309561A (zh) | 2001-08-22 |
| AU7454898A (en) | 1998-12-30 |
| NO995823D0 (no) | 1999-11-26 |
| CA2291256A1 (en) | 1998-12-03 |
| EP0992240A4 (en) | 2003-04-16 |
| KR20010012995A (ko) | 2001-02-26 |
| BR9809508A (pt) | 2000-06-20 |
| EP0992240A1 (en) | 2000-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL132993A0 (en) | Therapeutic agent for erection failure | |
| GB9725782D0 (en) | Therapeutic agents | |
| GB9708484D0 (en) | Therapeutic agents | |
| GB9718833D0 (en) | Therapeutic agents | |
| GB9708945D0 (en) | Therapeutic agents | |
| GB9704948D0 (en) | Therapeutic agents | |
| GB9702524D0 (en) | Therapeutic agents | |
| GB9711753D0 (en) | Therapeutic agents | |
| GB9713707D0 (en) | Therapeutic agents | |
| GB9715977D0 (en) | Therapeutic agents | |
| GB9711114D0 (en) | Therapeutic agents | |
| HUP0300615A3 (en) | Therapeutic agents | |
| GB9723544D0 (en) | Therapeutic agents | |
| GB9702392D0 (en) | Therapeutic agents | |
| SG106561A1 (en) | Therapeutic agents for macromolecular structures | |
| GB9700555D0 (en) | Therapeutic agents | |
| GB9725126D0 (en) | Therapeutic agents | |
| GB9718254D0 (en) | Therapeutic agents | |
| GB9716463D0 (en) | Therapeutic agents | |
| GB9716457D0 (en) | Therapeutic agents | |
| GB9710745D0 (en) | Therapeutic agents | |
| GB9716471D0 (en) | Therapeutic agents | |
| GB9710747D0 (en) | Therapeutic agents | |
| GB9723741D0 (en) | Therapeutic agents | |
| GB9716491D0 (en) | Therapeutic agents |